Linked Life Data

18852553

Source:http://linkedlifedata.com/resource/pubmed/id/18852553

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-10-14
pubmed:abstractText
A previous thrombotic event and advanced age are well-known risk factors for thrombosis in essential thrombocythemia (ET). In these patients, therefore, cytotoxic drugs are needed to reduce platelet count. In spite of this convincing idea, in clinical practice, some old patients do not use platelet-reducing drugs, for a variety of causes, and few specific studies in old patients with ET are available. Our retrospective study reports single-center experience in 54 old ET patients with long follow-ups.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1594-0667
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
376-80
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Hydroxyurea in old patients with essential thrombocythemia.
pubmed:affiliation
Internal Medicine, Department of Medical and Surgical Sciences, University of Padova, 35128 Padova, Italy. marialuigia.randi@unipd.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't